Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms 18F-flortanidazole, Flortanidazole F 18, Flortinidazole (18F) + [1] |
Target- |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC9H11FN6O3 |
InChIKeyZSSPATINHRVRTN-LMANFOLPSA-N |
CAS Registry1070878-86-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Phase 2 | US | - | |
Head and Neck Neoplasms | Phase 2 | - | - | |
Head and Neck Neoplasms | Phase 2 | - | - | |
Head and Neck Neoplasms | Phase 2 | AU | - | |
Head and Neck Neoplasms | Phase 2 | US | - | |
Head and Neck Neoplasms | Phase 2 | AU | - | |
Head and Neck Neoplasms | Phase 2 | - | - | |
Head and Neck Neoplasms | Phase 2 | - | - | |
Non-Small Cell Lung Cancer | Phase 2 | - | - | |
Non-Small Cell Lung Cancer | Phase 2 | - | - |
Phase 2 | 50 | vdhvatipbq(srhhoebvnn) = wcvoqhyauf qzgmoqydox (gicuqbzoel, joczucuixl - tszvzsjjhe) View more | - | 30 Aug 2013 |